135 related articles for article (PubMed ID: 27275236)
1. Evaluation of C-Reactive Protein in Patients with Chronic Obstructive Pulmonary Disease.
Simonovska L; Ahmeti I; Mitreski V
Open Access Maced J Med Sci; 2015 Jun; 3(2):283-6. PubMed ID: 27275236
[TBL] [Abstract][Full Text] [Related]
2. Application Value of Blood Heparin-Binding Protein in the Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Dong Y; Zhou X; Zhang Y; Liu Y; Zhou X; Ren G; Li Q
Contrast Media Mol Imaging; 2021; 2021():3800211. PubMed ID: 35024012
[TBL] [Abstract][Full Text] [Related]
3. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
[TBL] [Abstract][Full Text] [Related]
5. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
6. Carotid Artery Disease and Lower Extremities Artery Disease in Patients with Chronic Obstructive Pulmonary Disease.
Buklioska-Ilievska D; Minov J; Kochovska-Kamchevska N; Gigovska I; Doneva A; Baloski M
Open Access Maced J Med Sci; 2019 Jul; 7(13):2102-2107. PubMed ID: 31456833
[TBL] [Abstract][Full Text] [Related]
7. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the level of selected parameters of inflammation, circulating immune complexes, and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases.
Pilaczyńska-Cemel M; Gołda R; Dąbrowska A; Przybylski G
Cent Eur J Immunol; 2019; 44(3):292-298. PubMed ID: 31871418
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure.
Aksu F; Capan N; Aksu K; Ofluoğlu R; Canbakan S; Yavuz B; Akin KO
J Thorac Dis; 2013 Aug; 5(4):414-21. PubMed ID: 23991296
[TBL] [Abstract][Full Text] [Related]
10. Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Kwon YS; Chi SY; Shin HJ; Kim EY; Yoon BK; Ban HJ; Oh IJ; Kim KS; Kim YC; Lim SC
J Korean Med Sci; 2010 Oct; 25(10):1487-91. PubMed ID: 20890431
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
[TBL] [Abstract][Full Text] [Related]
12. Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001.
Melbye H; Halvorsen DS; Hartz I; Medbø A; Brox J; Eggen AE; Njølstad I
Respir Med; 2007 Dec; 101(12):2541-9. PubMed ID: 17825547
[TBL] [Abstract][Full Text] [Related]
13. Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease.
Areias V; Carreira S; Anciães M; Pinto P; Bárbara C
Rev Port Pneumol; 2014; 20(1):5-11. PubMed ID: 23993405
[TBL] [Abstract][Full Text] [Related]
14. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction.
Fruchter O; Rosengarten D; Goldberg E; Ben-Zvi H; Tor R; Kramer MR
Clin Respir J; 2016 Mar; 10(2):239-45. PubMed ID: 25196428
[TBL] [Abstract][Full Text] [Related]
15. Systemic Galectin-3 in Smokers with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis: The Impact of Exacerbations.
Sundqvist M; Andelid K; Ekberg-Jansson A; Bylund J; Karlsson-Bengtsson A; Lindén A
Int J Chron Obstruct Pulmon Dis; 2021; 16():367-377. PubMed ID: 33642857
[TBL] [Abstract][Full Text] [Related]
16. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mohan M; Parthasarathi A; S K C; Biligere Siddaiah J; Mahesh PA
Cureus; 2021 Aug; 13(8):e16864. PubMed ID: 34367840
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations.
Karadeniz G; Polat G; Senol G; Buyuksirin M
Inflammation; 2013 Aug; 36(4):948-53. PubMed ID: 23547018
[TBL] [Abstract][Full Text] [Related]
20. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
